Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Indorama Ventures PCL's average EBITDA Per Share Growth Rate was 70.60% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -24.40% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -9.80% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 0.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Indorama Ventures PCL was 52.20% per year. The lowest was -29.70% per year. And the median was 7.60% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Indorama Ventures PCL 3-Year EBITDA Growth Rate Related Terms
INDOY vs DOW: 3-Year EBITDA Growth Rate Comparison
For the Chemicals subindustry, Indorama Ventures PCL's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indorama Ventures PCL 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Indorama Ventures PCL's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Indorama Ventures PCL's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of -24.40% mean?
Indorama Ventures PCL (INDOY) has a 3-Year EBITDA Growth Rate of -24.40% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Indorama Ventures PCL and its competitors. According to the industry distribution chart, Indorama Ventures PCL ranks #1219 out of 1408 companies in the Chemicals industry, placing it in the top 86.6%.
Is Indorama Ventures PCL's 3-Year EBITDA Growth Rate too high?
Indorama Ventures PCL's current 3-Year EBITDA Growth Rate is -24.40%. Based on the distribution chart, Indorama Ventures PCL ranks #1219 out of 1408 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Indorama Ventures PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Indorama Ventures PCL's 3-Year EBITDA Growth Rate compare to DOW?
According to the Chemicals industry distribution chart, Indorama Ventures PCL ranks #1219 out of 1408 companies for 3-Year EBITDA Growth Rate. This places Indorama Ventures PCL in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 0.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.85, based on 1,408 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Indorama Ventures PCL and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indorama Ventures PCL's current 3-Year EBITDA Growth Rate is -24.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indorama Ventures PCL stock overvalued right now?
Indorama Ventures PCL (INDOY) has a current 3-Year EBITDA Growth Rate of -24.40%. The stock's GF Value™ is $5.66, compared to a current price of $7.03 — trading 24.2% above its estimated fair value. The current 3-Year EBITDA Growth Rate is -24.40%. Indorama Ventures PCL's overall GF Score™ is 59/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Indorama Ventures PCL (INDOY), the current 3-Year EBITDA Growth Rate is -24.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indorama Ventures PCL (INDOY) Overvalued in 2026?
Based on GuruFocus' analysis, Indorama Ventures PCL stock appears to be overvalued.
The current stock price of $7.03 is trading 24.2% above its estimated GF Value™ of $5.66.
Key valuation signals for INDOY:
3-Year EBITDA Growth Rate: -24.40%
GF Value™: $5.66 vs. price of $7.03 (24.2% above fair value)
No single metric tells the full story. See the INDOY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indorama Ventures PCL is engaged in the manufacture and distribution of Polyethylene Terephthalate, Purified Terephthalic Acid, Paraxylene, recycling, Purified Isophthalic Acid, Naphthalene Dicarboxylate, PET preforms and packaging, Integrated EG, Integrated purified EO, PO/MTBE, Integrated Surfactants comprising EOA, LAB and others, Fibers including Polyester, Rayon, Nylon, Polypropylene, composites and worsted wool fibers products. The company operates in three reportable segments Combined PET, Integrated Oxides and Derivatives and Fibers. The maximum revenue is derived from the Combined PET segment.
59GF Score
Get the complete analysis for INDOY
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INDOY has been successfully added to your 
